Post by PressRelease on Jan 15, 2024 1:00am
New Press Release - Sirona Biochem Launches Cosmetics Subsidiary- Sirona Laboratories(TM)
Comment by
Pandora on Jan 15, 2024 2:28am
Doesn't say anything about it being a spin out to favour existing shareholders. Wonder how they will organize it share wise -- if any change at all?
Comment by
lscfa on Jan 15, 2024 8:16am
It's an attempt to raise funds via a non-public subsidiary at a price level that is higher than SBM's public stock price. Still dilution.
Comment by
lscfa on Jan 15, 2024 11:48am
SBM mkt cap $30M. If they raise $10M for a 25% stake in Sirona Labs then 1326 is worth $40M on its own.
Comment by
lscfa on Jan 15, 2024 11:55am
Assume 1326 is worth $100M. Do $10M raise for 10% of SL. SBM still owns 90% of SL worth $90 or $0.36/sh.
Comment by
tylerreddick on Jan 15, 2024 12:14pm
You would think SBM should be worth a lot more than 11 stinkin cents, but there are a heck of a lot of people who don't think so, by the look of the heavy selling today. One thing I do know is that anyone who sells on every fluff news release Howie puts out has made a heck of a lot more money than anyone holding out for the "big payoff", the payoff that never seems to materialize.
Comment by
forhandlaren on Jan 15, 2024 3:31pm
We tend to forget USD vs CAD. Deals usually refers to USD and the share is based on CAD. The conversion factor is usually 1.33 hence 0.48 cents in the example given.
Comment by
biorun on Jan 15, 2024 4:05pm
Yes, and you add the commercialization of TFC 1067 with Allergan and that number, in NPV terms per share, goes up another sizeable amount. When these guys announce private equity and ramp up details, we will know this is on the money train with these uncertainties derisked. Those that get in early and take measured investment risks have that longer term payoff potential.